Harrow, Inc. partners with Apotex Inc. to enhance Canadian eyecare market
In a landmark development for the Canadian healthcare industry, Harrow, Inc. (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, and Apotex Inc., Canada’s largest pharmaceutical company, have jointly announced an exclusive out-licensing agreement. This strategic alliance is set to revolutionize the Canadian eyecare market by introducing a suite of innovative ophthalmic treatments. Under this exclusive […]